Literature DB >> 6807390

Absorption of isophane (NPH) insulin and its clinical implications.

T Lauritzen, S Pramming, E A Gale, T Deckert, C Binder.   

Abstract

Absorption of 125I-NPH insulin (125I-isophane insulin) (40 IU/ml) was studied in eight diabetics given 50% and 150% of their normal daily dose of insulin. Insulin absorption correlated with plasma insulin (r = 0.97, p less than 0.001) and blood glucose (r = -0.87, p less than 0.01) concentrations. Absorption was slower at higher doses, so that trebling the insulin dose only doubled the amount absorbed over the first 24 hours. The plasma elimination half time (t12) of insulin was about five minutes. Thus, the disappearance of radiolabelled insulin is a reliable and quantitative index of insulin absorption; subcutaneous degradation, if present, is minimal and constant. Changes in dise of intermediate-acting insulin further increases the large variation in insulin absorption. This implies that minor adjustments of intermediate insulin dosage are probably futile.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6807390      PMCID: PMC1499314          DOI: 10.1136/bmj.285.6336.159

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  11 in total

1.  Absorption of protamine-insulin in diabetic patients. I. Preparation and characterization of protamine-125I-insulin.

Authors:  B Hansen; S Linde; K Kølendorf; F Jensen
Journal:  Horm Metab Res       Date:  1979-02       Impact factor: 2.936

2.  Peripheral blood flow and metabolic control in juvenile diabetes.

Authors:  H J Gundersen
Journal:  Diabetologia       Date:  1974-06       Impact factor: 10.122

3.  Determination of total serum insulin (IRI) in insulin-treated diabetic patients.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1972-08       Impact factor: 10.122

4.  The effect of aprotinin on the absorption of subcutaneously injected regular insulin in normal subjects.

Authors:  M Berger; H J Cüppers; P A Halban; R E Offord
Journal:  Diabetes       Date:  1980-01       Impact factor: 9.461

5.  Role of continuous component in subcutaneous "open-loop" insulin delivery.

Authors:  J D Nelson; E B Marliss; A M Albisser; B Zinman
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

6.  Subcutaneous degradation of insulin.

Authors:  T Deckert; B Hansen; T Lauritzen; J S Christiansen
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

7.  Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.

Authors:  M Berger; P A Halban; L Girardier; J Seydoux; R E Offord; A E Renold
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

8.  Variation in 125I-insulin absorption and blood glucose concentration.

Authors:  T Lauritzen; O K Faber; C Binder
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

9.  Time-action characteristics of regular and NPH insulin in insulin-treated diabetics.

Authors:  B Roy; M C Chou; J B Field
Journal:  J Clin Endocrinol Metab       Date:  1980-03       Impact factor: 5.958

10.  Patient self-monitoring of blood glucose and refinements of conventional insulin treatment.

Authors:  R Tattersall; E Gale
Journal:  Am J Med       Date:  1981-01       Impact factor: 4.965

View more
  13 in total

Review 1.  Insulin injection technique.

Authors:  J Thow; P Home
Journal:  BMJ       Date:  1990-07-07

2.  Biochemical and physiological properties of a novel series of long-acting insulin analogs obtained by acylation with cholic acid derivatives.

Authors:  Ib Jonassen; Svend Havelund; Ulla Ribel; Anne Plum; Mette Loftager; Thomas Hoeg-Jensen; Aage Volund; Jan Markussen
Journal:  Pharm Res       Date:  2006-12-21       Impact factor: 4.200

Review 3.  Insulin.

Authors:  J N MacPherson; J Feely
Journal:  BMJ       Date:  1990-03-17

4.  Change to U-100 insulin does not appear to affect insulin absorption.

Authors:  P G Swift; J D Kennedy; L S Gerlis
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-26

5.  Pharmacokinetics of continuous subcutaneous insulin infusion.

Authors:  T Lauritzen; S Pramming; T Deckert; C Binder
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

6.  NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.

Authors:  S Jørgensen; A Vaag; L Langkjaer; P Hougaard; J Markussen
Journal:  BMJ       Date:  1989-08-12

7.  An analysis of the mixing efficiency of neutral protamine Hagedorn cartridges.

Authors:  Scott V Monte; Patrick Comerford; Natalie Dearing
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

8.  Study of porcine and human isophane (NPH) insulins in normal subjects.

Authors:  D R Owens; I R Jones; A J Birtwell; C T Burge; S Luzio; C J Davies; P Heyburn; L G Heding
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

9.  Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes.

Authors:  Eda Cengiz; William V Tamborlane; Melody Martin-Fredericksen; James Dziura; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 19.112

Review 10.  Features, prevention and management of acute overdose due to antidiabetic drugs.

Authors:  D F Moore; D F Wood; G N Volans
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.